Canada, February 7, 2020 (420 INTEL)- One recent survey reported that upwards of 66% of those who suffer from MS may use cannabis in their efforts to control the disease. Multiple sclerosis, also known as MS, is a chronic autoimmune disease that affects the central nervous system (CNS) — brain and spinal cord — by damaging the fatty myelin …
Read More »
U.S., February 6, 2020 (Hemp Industry Daily)- Hemp entrepreneurs in California are optimistic that long-awaited state legislation to legalize hemp-derived CBD as an ingredient in food, beverages and cosmetics will be revived from suspension and ready for Gov. Gavin Newsom to approve by spring. A coalition of hemp farmers, advocates and local …
Read More »
TORONTO, Feb. 5, 2020 /CNW/ – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”) announces that Raza Bokhari, MD, Executive Co-Chairman and Chief Executive Officer, accompanied by FSD Pharma Biosciences leadership, will be participating in the 22nd Annual BIO CEO & Investor conference, including presenting a company overview at 9:45 a.m. ET on Monday, February 10, 2020. About …
Read More »
Australia, February 3, 2020 (HEMPGAZETTE)- Some widely held assumptions on THC levels in hemp have been put under the spotlight in a recent study. While hemp has far less of the intoxicating cannabinoid tetrahydrocannabinol (THC) than its cousin marijuana (low THC levels are what makes a cannabis sativa plant hemp …
Read More »
Due to the growth of the hemp industry, demand for specialized hemp processing equipment has surpassed the supply. U.S., January 25, 2020 (cannabis tech)- Due to the growth of the hemp industry, demand for specialized hemp processing equipment has surpassed the supply. As many entrepreneurs have discovered, finding machinery equipped …
Read More »
U.S., February 4, 2020 (proactive)- The project is determining if its algal expression system can create pharmaceutical-grade cannabinoids. To enable Solarvest to accelerate the pace of the research, FSD Pharma has issued a further 225,371 of its shares FSD Pharma Inc (CSE:HUGE) (NASDAQ:HUGE), the specialty biotech, revealed it had amended its …
Read More »
U.S., February 2, 2020 (420 INTEL) – It is estimated that as many as 88 percent of older individuals around the world suffer from chronic pain. It’s no secret that as the body ages, aches and pains become more common. Chronic pain can be very miserable to live with and can have a …
Read More »
Canada, February 4, 2020 (420 INTEL)- Canada’s pot producers are getting plenty of fresh air. For the first time, Health Canada noted it has licenced more physical space for outdoor cannabis cultivation (19 million sq. ft.) than indoor grow ops (13 million sq. ft.). The abundance of outdoor operations should …
Read More »
Australia, January 27, 2020 (HEMPGAZETTE)- A bunch of celebrities have been jumping on the medical and adult-use cannabis bandwagon. Where they haven’t; some have been pushed onto it – without permission. The last thing a relatively new industry needs are snake-oil salesmen and shonky marketing tactics, particularly where that industry …
Read More »
Prior to discussing the recent legal developments in the field of medical cannabis, it is important to distinguish between medical cannabis and EU-approved medicinal products derived from cannabis. Medical cannabis is cannabis grown for medical purposes, whereas EU-approved medicinal products encompass certain medicines derived from cannabis and containing an amount …
Read More »Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.
Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.
Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.
Investment Value Finders is intended for those 21+ years of age only!
Investment value finders Investment value finders